Stifel analysts initiated coverage on Cytokinetics shares (NASDAQ:CYTK), assigning a Buy rating and setting a price target of ...

Stifel analysts, led by Brian Chin, reaffirmed their Hold rating on shares of FormFactor (NASDAQ:FORM), with a steady price ...

Stifel lowered the firm’s price target on Fastenal (FAST) to $82 from $86 and keeps a Hold rating on the shares. Despite the ...

Stifel analyst Drew Crum raised the firm’s price target on Take-Two (TTWO) to $223 from $220 and keeps a Buy rating on the shares. The firm ...

Wall Street analysts are buzzing with optimism as we step into 2025.  There are plenty of reasons for a positive view to ...

Canadian investment dealer Eight Capital Corp. is winding down and many of its top staff are headed to Stifel Financial Corp.

Altimmune Inc (ALT) stock saw a modest uptick, ending the day at $6.86 which represents a slight increase of $0.15 or 2.24% from the prior close of $6.71. The stock opened at $6.8 and touched a low of ...

Stifel downgrades cybersecurity stocks Rapid7 and Tenable to Hold, citing cautious stance on vulnerability management.

Stifel analyst Adam Borg downgraded Rapid7 (RPD) to Hold from Buy with a price target of $42, down from $48, following a transfer of coverage.

Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by ...

On Friday, Canoo Inc (GOEV) stock saw a decline, ending the day at $1.35 which represents a decrease of $-0.16 or -10.60% from the prior close of $1.51. The stock opened at $1.51 and touched a low of ...

Stifel analyst Benjamin J. Nolan upgraded Canadian National Railway Company (NYSE:CNI) to Buy from Hold while reducing the ...